ENTX
Entera Bio·NASDAQ
--
--(--)
--
--(--)
3.59 / 10
Netural
Fund flow evaluation is 7.18/10, suggesting liquidity inflows are supportive. However, analyst coverage is minimal and the consensus rating is Strong Buy with zero historical win rate, limiting its reliability. The combination of positive fund flow but negative price trend underscores the need for caution.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-03-18
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of ENTX?
- ENTX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.59/10 (Netural).
